Pulmonary Tuberculosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Pulmonary Tuberculosis Clinical Trials Market Report Overview
The Pulmonary Tuberculosis clinical trial market research report provides an overview of the Pulmonary Tuberculosis Clinical trials scenario. This report provides top-line data relating to the clinical trials on Pulmonary Tuberculosis and an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. It also provides prominent drugs for in-progress trials (based on the number of ongoing trials).
Key Regions | · North America
· Asia-Pacific · Europe · Middle East & Africa · South & Central America |
Key Countries | · South Africa
· China · India · Russia · United States · Uganda · Tanzania · Philippines · Thailand · Brazil |
Key Sponsor Types | · Institution
· Company · Government |
Leading Sponsors | · Johnson & Johnson
· Otsuka Holdings Co Ltd · Pharmasyntez · GSK plc · Sanofi |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Pulmonary Tuberculosis Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Pulmonary Tuberculosis clinical trials market are North America, Asia-Pacific, Europe, the Middle East & Africa, and South & Central America, among others. Asia-Pacific dominates the market with more than 40% of the clinical trials conducted sas of July 2023.
In the country-wise analysis, South Africa has the highest number of pulmonary tuberculosis clinical trials, as of July 2023. Tanzania has the highest average patient enrollment of pulmonary tuberculosis clinical trials, as of July 2023.
G7 and E7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the UK has the highest proportion of Pulmonary Tuberculosis to Infectious disease clinical trials as of July 2023. While, in the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of Pulmonary Tuberculosis to Infectious disease clinical trials as of July 2023.
Pulmonary Tuberculosis Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the Pulmonary Tuberculosis clinical trials market, download a free report sample
Pulmonary Tuberculosis Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Pulmonary Tuberculosis clinical trials market are institution, company, and the government. Out of them, the institution sponsor type dominates the market.
Pulmonary Tuberculosis Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the Pulmonary Tuberculosis clinical trials market, download a free report sample
Pulmonary Tuberculosis Clinical Trials Market - Competitive Landscape
The leading sponsors in the Pulmonary Tuberculosis clinical trials market are Johnson & Johnson, Otsuka Holdings Co Ltd, Pharmasyntez, GSK plc, and Sanofi among others. Johnson & Johnson led the Pulmonary Tuberculosis clinical trials market in July 2023.
Pulmonary Tuberculosis Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading sponsors in the Pulmonary Tuberculosis clinical trials market, download a free report sample
Segments Covered in the Report
Pulmonary Tuberculosis Clinical Trials Regional Outlook (2023)
- North America
- Asia-Pacific
- Europe
- Middle East & Africa
- South & Central America
Pulmonary Tuberculosis Clinical Trials Country Outlook (2023)
- South Africa
- China
- India
- Russia
- United States
- Uganda
- Tanzania
- Philippines
- Thailand
- Brazil
Pulmonary Tuberculosis Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies concerning investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Otsuka Holdings Co Ltd
Pharmasyntez
GSK plc
Sanofi
IQVIA Holdings Inc
Cadila Pharmaceuticals Ltd
LegoChem Biosciences Inc
Chengdu Keen Biotechnology Co Ltd
Sequella Inc
Table of Contents
Frequently asked questions
-
Which was the leading region in the Pulmonary Tuberculosis clinical trials market?
Asia Pacific was the leading region in the Pulmonary Tuberculosis clinical trials market as of July 2023.
-
Which was the leading country in the Pulmonary Tuberculosis clinical trials market?
South Africa was the leading country in the Pulmonary Tuberculosis clinical trials market as of July 2023.
-
Which was the leading sponsor type in the Pulmonary Tuberculosis clinical trials market?
Institution was the leading sponsor type in the Pulmonary Tuberculosis clinical trials market as of July 2023.
-
Who are the leading sponsors in the Pulmonary Tuberculosis clinical trials market?
The leading sponsors in the Pulmonary Tuberculosis clinical trials market are Johnson & Johnson, Otsuka Holdings Co Ltd, Pharmasyntez, GSK plc, and Sanofi among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Pulmonary Tuberculosis reports

